Nasdaq · Common stock
Starling Oncology (STLN)
$6.29 −$0.42 (−6.26%)
- Day’s range
- $6.19–$6.81
- Volume
- 1.9M
STLN price history
STLN closed at $6.29 on Oct. 26, 2026. Over the past year, its daily close ranged from $4.99 on Aug. 6, 2026 to $7.05 on Sept. 22, 2026.
Data table: STLN daily closes, the past year
| Date | Close |
|---|---|
| Oct. 26, 2026 | $6.29 |
| Oct. 23, 2026 | $6.71 |
| Oct. 22, 2026 | $6.91 |
| Oct. 21, 2026 | $6.83 |
| Oct. 20, 2026 | $6.63 |
| Oct. 19, 2026 | $6.46 |
| Oct. 16, 2026 | $6.43 |
| Oct. 15, 2026 | $6.91 |
| Oct. 14, 2026 | $6.51 |
| Oct. 13, 2026 | $6.70 |
| Oct. 12, 2026 | $6.92 |
| Oct. 9, 2026 | $6.63 |
| Oct. 8, 2026 | $6.18 |
| Oct. 7, 2026 | $6.43 |
| Oct. 6, 2026 | $6.58 |
| Oct. 5, 2026 | $6.30 |
| Oct. 2, 2026 | $6.35 |
| Oct. 1, 2026 | $6.22 |
| Sept. 30, 2026 | $6.32 |
| Sept. 29, 2026 | $6.51 |
| Sept. 28, 2026 | $6.64 |
| Sept. 25, 2026 | $6.66 |
| Sept. 24, 2026 | $6.51 |
| Sept. 23, 2026 | $6.82 |
| Sept. 22, 2026 | $7.05 |
| Sept. 21, 2026 | $6.83 |
| Sept. 18, 2026 | $6.96 |
| Sept. 17, 2026 | $6.63 |
| Sept. 16, 2026 | $6.53 |
| Sept. 15, 2026 | $6.37 |
| Sept. 14, 2026 | $6.52 |
| Sept. 11, 2026 | $6.17 |
| Sept. 10, 2026 | $6.20 |
| Sept. 9, 2026 | $6.29 |
| Sept. 8, 2026 | $6.32 |
| Sept. 4, 2026 | $5.93 |
| Sept. 3, 2026 | $5.97 |
| Sept. 2, 2026 | $6.09 |
| Sept. 1, 2026 | $5.94 |
| Aug. 31, 2026 | $5.91 |
| Aug. 28, 2026 | $6.17 |
| Aug. 27, 2026 | $6.34 |
| Aug. 26, 2026 | $6.56 |
| Aug. 25, 2026 | $6.30 |
| Aug. 24, 2026 | $6.13 |
| Aug. 21, 2026 | $6.47 |
| Aug. 20, 2026 | $6.54 |
| Aug. 19, 2026 | $6.66 |
| Aug. 18, 2026 | $6.40 |
| Aug. 17, 2026 | $6.31 |
| Aug. 14, 2026 | $6.45 |
| Aug. 13, 2026 | $6.26 |
| Aug. 12, 2026 | $6.32 |
| Aug. 11, 2026 | $6.20 |
| Aug. 10, 2026 | $6.16 |
| Aug. 7, 2026 | $6.41 |
| Aug. 6, 2026 | $4.99 |
| Aug. 5, 2026 | $5.03 |
| Aug. 4, 2026 | $5.17 |
Key figures
- 52-week range
- —
- Average daily volume
- 1.4MPast 3 months
- Market value
- $628.9M
- Dividend yield
- —
- From 52-week high
- —
Price change
- 1 month
- −5.56%
- 3 months
- —
- Year to date
- —
- 1 year
- —
What Wall Street says about STLN
In the past 90 days, Wall Street firms published 1 rating or price-target action on STLN: 1 raised price target.
| Action | Rating | |||
|---|---|---|---|---|
| Needham | Raises target | Buy | $7 to $9 |
Ratings and price targets are the firms’ own opinions, reported as published.
Not investment advice.
About Starling Oncology, Inc. Common Stock
Starling Oncology Inc provides oncology care services in community settings. Its services include cancer diagnosis and treatment, clinical trials, transfusion services, and other oncology care delivery models for patients.
- Headquarters
- Cerritos, Calif.
- Employees
- 641
- Listed
- Nov. 15, 2021
- Industry
- Services-offices & clinics of doctors of medicine
In WallStreetDigest editions
No WallStreetDigest article about STLN is on the site yet.